Showing 721 - 740 results of 99,686 for search '(( 5 ht decrease ) OR ( 5 ((step decrease) OR (((teer decrease) OR (a decrease)))) ))', query time: 1.39s Refine Results
  1. 721

    dsRNAi construct effectively reduces 5-HT<sub>7</sub>Dro transcript levels. by Jaime Becnel (218896)

    Published 2011
    “…Flies carrying both transcripts show an approximately 80% decrease in 5-HT<sub>7</sub>Dro transcript levels. …”
  2. 722
  3. 723
  4. 724

    Image_1.pdf by Vicky Pauwelyn (4920385)

    Published 2018
    “…<p>Background: As the signal transduction of 5-HT<sub>4</sub> receptors on cholinergic neurons innervating smooth muscle is controlled by phosphodiesterase (PDE) 4 in porcine stomach and colon, and human large intestine, the in vivo gastroprokinetic effects of a 5-HT<sub>4</sub> receptor agonist might be enhanced by combination with a selective PDE4 inhibitor. …”
  5. 725
  6. 726
  7. 727
  8. 728
  9. 729
  10. 730
  11. 731
  12. 732
  13. 733
  14. 734
  15. 735
  16. 736
  17. 737
  18. 738
  19. 739

    Image1_The 5HT4R agonist velusetrag efficacy on neuropathic chronic intestinal pseudo-obstruction in PrP-SCA7-92Q transgenic mice.JPEG by Yongqiang Liu (651861)

    Published 2024
    “…Herein, we report the characterization of the PrP-SCA7-92Q transgenic (Tg) line as a valuable CIPO mouse model and investigated the tolerability and efficacy of the 5-hydroxytryptamine type-4 receptor (5HT4R) agonist velusetrag as a promising pharmacological treatment for CIPO.…”
  20. 740

    Image3_The 5HT4R agonist velusetrag efficacy on neuropathic chronic intestinal pseudo-obstruction in PrP-SCA7-92Q transgenic mice.JPEG by Yongqiang Liu (651861)

    Published 2024
    “…Herein, we report the characterization of the PrP-SCA7-92Q transgenic (Tg) line as a valuable CIPO mouse model and investigated the tolerability and efficacy of the 5-hydroxytryptamine type-4 receptor (5HT4R) agonist velusetrag as a promising pharmacological treatment for CIPO.…”